These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32055544)

  • 1. Population pharmacokinetic analysis of metformin administered as fixed-dose combination in Korean healthy adults.
    Choi S; Jeon S; Han S
    Transl Clin Pharmacol; 2018 Mar; 26(1):25-31. PubMed ID: 32055544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population PK/PD analysis of metformin using the signal transduction model.
    Chae JW; Baek IH; Lee BY; Cho SK; Kwon KI
    Br J Clin Pharmacol; 2012 Nov; 74(5):815-23. PubMed ID: 22380769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
    Chang M; Liu X; Cui D; Liang D; LaCreta F; Griffen SC; Lubin S; Quamina-Edghill D; Boulton DW
    Clin Ther; 2015 Jul; 37(7):1517-28. PubMed ID: 26048185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetic Modeling of Canagliflozin in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus.
    Hoeben E; De Winter W; Neyens M; Devineni D; Vermeulen A; Dunne A
    Clin Pharmacokinet; 2016 Feb; 55(2):209-23. PubMed ID: 26293616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: a randomized, open-label, multiple dose, crossover study.
    Park SM; Lee J; Seong SJ; Park JG; Gwon MR; Lim MS; Lee HW; Yoon YR; Yang DH; Kwon KI; Han S
    BMC Pharmacol Toxicol; 2014 Dec; 15():75. PubMed ID: 25534747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic comparison of 2 formulations of anastrozole (1 mg) in healthy Korean male volunteers: a randomized, single-dose, 2-period, 2-sequence, crossover study.
    Noh YH; Ko YJ; Cho SH; Ghim JL; Choe S; Jung JA; Kim UJ; Jin SJ; Park HJ; Song GS; Lim HS; Bae KS
    Clin Ther; 2012 Feb; 34(2):305-13. PubMed ID: 22281018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China.
    Song L; Cao F; Niu S; Xu M; Liang R; Ding K; Lin Z; Yao X; Liu D
    Clin Pharmacokinet; 2024 Jan; 63(1):93-108. PubMed ID: 37985591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic modeling and noncompartmental analysis demonstrated bioequivalence between metformin component of metformin/vildagliptin fixed-dose combination products and metformin immediate-release tablet sourced from various countries.
    Chitnis SD; Han Y; Yamaguchi M; Mita S; Zhao R; Sunkara G; Kulmatycki K
    Clin Pharmacol Drug Dev; 2016 Jan; 5(1):40-51. PubMed ID: 27119577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence and Food Effect of Dapagliflozin/Saxagliptin/Metformin Extended-release Fixed-combination Drug Products Compared With Coadministration of the Individual Components in Healthy Subjects.
    Tang W; Engman H; Zhu Y; Dayton B; Boulton DW
    Clin Ther; 2019 Aug; 41(8):1545-1563. PubMed ID: 31266654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic comparisons between two formulations containing 100 mg of miglitol in healthy male Korean volunteers: a randomized, open-label, single-dose, two-period, two-sequence crossover bioequivalence study.
    Choi HG; Jeon JY; Im YJ; Kim Y; Jang H; Kang S; Kim KH; Chae SW; Lee SY; Kim MG
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):55-63. PubMed ID: 24290415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics (PK) and Pharmacodynamics (PD) Analysis of LY3015014, a Monoclonal Antibody to Protein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Healthy Subjects and Hypercholesterolemia Patients.
    Shen T; James DE; Krueger KA
    Pharm Res; 2017 Jan; 34(1):185-192. PubMed ID: 27822850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic modeling analysis of cilostazol and its active metabolites (OPC-13015 and OPC-13213) after multiple oral doses of cilostazol in healthy Korean volunteers.
    Cui A; Kim YH; Ghim JL; Ah Jung J; Cho SH; Choe S; Choi HY; Bae KS; Lim HS
    Xenobiotica; 2020 Mar; 50(3):288-296. PubMed ID: 31181990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a fixed-dose glimepiride/sustained-release metformin combination.
    Kim KP; Lim KS; Kim BH; Shin HS; Cho JY; Shin SG; Jang IJ; Yu KS
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):142-9. PubMed ID: 22257580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms.
    Jeong SH; Jang JH; Cho HY; Lee YB
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects.
    Jiang X; Yu KS; Nam DH; Oh J
    Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-dependent pharmacokinetic analysis of enalapril administered to healthy adult volunteers using orodispersible minitablets for use in pediatrics.
    Faisal M; Cawello W; Burckhardt BB; Laer S
    Drug Des Devel Ther; 2019; 13():481-490. PubMed ID: 30774312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of fluticasone propionate/salmeterol using two different dry powder inhalers.
    Soulele K; Macheras P; Silvestro L; Rizea Savu S; Karalis V
    Eur J Pharm Sci; 2015 Dec; 80():33-42. PubMed ID: 26296862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
    Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
    Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.